Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depigoid Phleum Dose Finding in Allergic Rhinitis
NCT01634958Phase 2Completed
- Sponsor
- LETI Pharma
- Start
- Oct 2012
- Primary completion
- Apr 2013
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of depigoid phleum in allergic rhinitis (AR), allergic rhinoconjunctivitis (ARC), sponsored by LETI Pharma. Started Oct 2012; status: completed.
02
Drugs
depigoid phleum
03
Conditions
allergic rhinitis (AR)allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT01634958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01634958.